Gilead Sciences Inc - Company & Market Research Reports

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment - Product Thumbnail Image

The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment

  • Report
  • 320 Pages
From
Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030 - Product Thumbnail Image

Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030

  • Report
  • 350 Pages
From
Hepatitis Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Hepatitis Drug Development Pipeline Review, 2018

  • Report
  • 133 Pages
From
Global Hepatitis Drug Market & Clinical Trials Insight 2023 - Product Thumbnail Image

Global Hepatitis Drug Market & Clinical Trials Insight 2023

  • Report
  • 550 Pages
From
HIV Drug Market by Medication class - Global Opportunity Analysis and Industry Forecast, 2014-2022 - Product Thumbnail Image

HIV Drug Market by Medication class - Global Opportunity Analysis and Industry Forecast, 2014-2022

  • Report
  • 163 Pages
From
 What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other]) - Product Thumbnail Image

What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other])

  • Report
  • 203 Pages
From
Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2024, NAIC 325412 - Product Thumbnail Image

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2024, NAIC 325412

  • Report
  • 73 Pages
From
HIV Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023 - Product Thumbnail Image

HIV Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023

  • Report
  • 73 Pages
From
Global Biologics Drug Discovery Market Analysis and Forecast, 2017-2025: Focus on Method/Phase, Product Type, Manufacturer Type and Competitive Landscape - Product Thumbnail Image

Global Biologics Drug Discovery Market Analysis and Forecast, 2017-2025: Focus on Method/Phase, Product Type, Manufacturer Type and Competitive Landscape

  • Report
  • 358 Pages
From
TCR Engineered T-Cell Therapy 2018: An Industry Analysis of Technologies, Pipelines, Stakeholders & Deals  - Product Thumbnail Image

TCR Engineered T-Cell Therapy 2018: An Industry Analysis of Technologies, Pipelines, Stakeholders & Deals

  • Report
  • 294 Pages
From
Global HIV Infection Drug Market & Pipeline Insight - Product Thumbnail Image

Global HIV Infection Drug Market & Pipeline Insight

  • Drug Pipelines
  • 1350 Pages
From
Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018

  • Report
  • 385 Pages
From
Global Hepatitis B Virus [HBV] Treatment Market - Analysis By Type (Therapeutics, Vaccine), By End User (Male, Female) - By Region, By Country: Opportunities and Forecast (2017-2022) - Product Thumbnail Image

Global Hepatitis B Virus [HBV] Treatment Market - Analysis By Type (Therapeutics, Vaccine), By End User (Male, Female) - By Region, By Country: Opportunities and Forecast (2017-2022)

  • Report
  • 180 Pages
From
NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis By Type, By End-Use (Pharma & CRO Industry, Hospitals, Diagnostic Labs, Academic Research Institutes), And Segment Forecasts, 2014 - 2025 - Product Thumbnail Image

NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis By Type, By End-Use (Pharma & CRO Industry, Hospitals, Diagnostic Labs, Academic Research Institutes), And Segment Forecasts, 2014 - 2025

  • Report
  • 100 Pages
From
Global Cancer Monoclonal Antibodies Market & Pipeline Insight - Product Thumbnail Image

Global Cancer Monoclonal Antibodies Market & Pipeline Insight

  • Drug Pipelines
  • 1400 Pages
From
Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Analysis By Drug Class And Segment Forecasts, 2014 - 2025 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Analysis By Drug Class And Segment Forecasts, 2014 - 2025

  • Report
  • 75 Pages
From
NASH (Non-alcoholic Steatohepatitis) biomarkers - Global Market Outlook (2017-2023) - Product Thumbnail Image

NASH (Non-alcoholic Steatohepatitis) biomarkers - Global Market Outlook (2017-2023)

  • Report
  • 185 Pages
From
Antibody Discovery: Services and Platforms, 2017-2027 - Product Thumbnail Image

Antibody Discovery: Services and Platforms, 2017-2027

  • Report
  • 306 Pages
From
Global Hepatitis Drugs Market – Drivers, Opportunities, Trends, and Forecasts: 2017–2023 - Product Thumbnail Image

Global Hepatitis Drugs Market – Drivers, Opportunities, Trends, and Forecasts: 2017–2023

  • Report
  • 87 Pages
From
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2018 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2018

  • Drug Pipelines
  • 1005 Pages
From
Loading Indicator
adroll